IndraLab

Statements

USP43 inhibits Carcinoma, Ovarian Epithelial. 1 / 1

| 1

reach

"USP43 impairs cisplatin sensitivity in epithelial ovarian cancer through HDAC2-dependent regulation of Wnt/beta-catenin signaling pathway."

38087046

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP43 inhibits Carcinoma, Ovarian Epithelial. 1 / 1

INDRA sources:

Databases

Reading